Adaptimmune Therapeutics Plc ADR [NASDAQ: ADAP] stock went on a downward path that fall over -8.98% on Thursday, amounting to a one-week price decrease of less than -30.36%. Over the last 12 months, ADAP stock dropped by -33.45%. The one-year Adaptimmune Therapeutics Plc ADR stock
Adaptimmune Therapeutics Plc ADR [NASDAQ: ADAP] price surged by 0.57 percent to reach at $0.01. The company report on March 6, 2024 at 7:00 AM that Adaptimmune Reports Q4/Full Year 2023 Financial Results and Business Updates. U.S. FDA accepted BLA for afami-cel for the treatment
Adaptimmune Therapeutics Plc ADR [NASDAQ: ADAP] jumped around 0.08 points on Tuesday, while shares priced at $0.87 at the close of the session, up 10.18%. The company report on January 4, 2024 at 7:37 AM that Adaptimmune Projects Sarcoma Franchise to Deliver US Peak Year
© 2024, Powered by Smart TechOne
